joining us live now is liz lindquist. her data journalist for the san francisco standard. thanks for joining us. >> thanks so much for having me. >> remind the people who are unfamiliar what the ozempic does and how it kind of became the darling of those seeking to shed weight. >> yeah. so ozempic is part of this class of medicines called semaglutide. you basically inject it into about once a week and it's developed as originally as a type two diabetes medication and there's a whole other slew of diabetes medications in this class. but ozempic is one that came out in around 2017, 2018. and it's really popular because it's easier to use. you only have to inject it once a week and it has really effective results for regulating your glucose levels as a diabetic and also for helping you lose weight. okay >> so it's become quite in demand aid and you started exploring the contradiction of san francisco. so not having a huge obesity problem yet. apparently a huge demand nonetheless. yeah >> yeah. i mean, i think what we're seeing in san francisco is something that's happening ac